Global Blood Glucose Device Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Blood Glucose Device will have significant change from previous year. According to our (LP Information) latest study, the global Blood Glucose Device market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Blood Glucose Device market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Blood Glucose Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Blood Glucose Device market, reaching US$ million by the year 2028. As for the Europe Blood Glucose Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Blood Glucose Device players cover Abbott Laboratories (U.S.), ARKRAY (Japan), Dexcom (U.S.), and F.Hoffmann-La Roche Ltd (Switzerland), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Glucose Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Blood Glucose Device will have significant change from previous year. According to our (LP Information) latest study, the global Blood Glucose Device market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Blood Glucose Device market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Blood Glucose Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Blood Glucose Device market, reaching US$ million by the year 2028. As for the Europe Blood Glucose Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Blood Glucose Device players cover Abbott Laboratories (U.S.), ARKRAY (Japan), Dexcom (U.S.), and F.Hoffmann-La Roche Ltd (Switzerland), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Glucose Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Blood Glucose Monitors
- Glucose Monitoring Strips
- Lancets
- Hospitals
- Diagnostics
- Home Settings
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories (U.S.)
- ARKRAY (Japan)
- Dexcom (U.S.)
- F.Hoffmann-La Roche Ltd (Switzerland)
- Johnson & Johnson (U.S.)
- Medtronic (U.S.)
- Nipro Diagnostics (U.S.)
- Terumo Medical Corporation (U.S.)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Glucose Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Blood Glucose Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Blood Glucose Device by Country/Region, 2017, 2022 & 2028
2.2 Blood Glucose Device Segment by Type
2.2.1 Blood Glucose Monitors
2.2.2 Glucose Monitoring Strips
2.2.3 Lancets
2.3 Blood Glucose Device Sales by Type
2.3.1 Global Blood Glucose Device Sales Market Share by Type (2017-2022)
2.3.2 Global Blood Glucose Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Blood Glucose Device Sale Price by Type (2017-2022)
2.4 Blood Glucose Device Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics
2.4.3 Home Settings
2.4.4 Others
2.5 Blood Glucose Device Sales by Application
2.5.1 Global Blood Glucose Device Sale Market Share by Application (2017-2022)
2.5.2 Global Blood Glucose Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Blood Glucose Device Sale Price by Application (2017-2022)
3 GLOBAL BLOOD GLUCOSE DEVICE BY COMPANY
3.1 Global Blood Glucose Device Breakdown Data by Company
3.1.1 Global Blood Glucose Device Annual Sales by Company (2020-2022)
3.1.2 Global Blood Glucose Device Sales Market Share by Company (2020-2022)
3.2 Global Blood Glucose Device Annual Revenue by Company (2020-2022)
3.2.1 Global Blood Glucose Device Revenue by Company (2020-2022)
3.2.2 Global Blood Glucose Device Revenue Market Share by Company (2020-2022)
3.3 Global Blood Glucose Device Sale Price by Company
3.4 Key Manufacturers Blood Glucose Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Glucose Device Product Location Distribution
3.4.2 Players Blood Glucose Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BLOOD GLUCOSE DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Blood Glucose Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Blood Glucose Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Blood Glucose Device Annual Revenue by Geographic Region
4.2 World Historic Blood Glucose Device Market Size by Country/Region (2017-2022)
4.2.1 Global Blood Glucose Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Blood Glucose Device Annual Revenue by Country/Region
4.3 Americas Blood Glucose Device Sales Growth
4.4 APAC Blood Glucose Device Sales Growth
4.5 Europe Blood Glucose Device Sales Growth
4.6 Middle East & Africa Blood Glucose Device Sales Growth
5 AMERICAS
5.1 Americas Blood Glucose Device Sales by Country
5.1.1 Americas Blood Glucose Device Sales by Country (2017-2022)
5.1.2 Americas Blood Glucose Device Revenue by Country (2017-2022)
5.2 Americas Blood Glucose Device Sales by Type
5.3 Americas Blood Glucose Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Glucose Device Sales by Region
6.1.1 APAC Blood Glucose Device Sales by Region (2017-2022)
6.1.2 APAC Blood Glucose Device Revenue by Region (2017-2022)
6.2 APAC Blood Glucose Device Sales by Type
6.3 APAC Blood Glucose Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood Glucose Device by Country
7.1.1 Europe Blood Glucose Device Sales by Country (2017-2022)
7.1.2 Europe Blood Glucose Device Revenue by Country (2017-2022)
7.2 Europe Blood Glucose Device Sales by Type
7.3 Europe Blood Glucose Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Glucose Device by Country
8.1.1 Middle East & Africa Blood Glucose Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Blood Glucose Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Blood Glucose Device Sales by Type
8.3 Middle East & Africa Blood Glucose Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Glucose Device
10.3 Manufacturing Process Analysis of Blood Glucose Device
10.4 Industry Chain Structure of Blood Glucose Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Glucose Device Distributors
11.3 Blood Glucose Device Customer
12 WORLD FORECAST REVIEW FOR BLOOD GLUCOSE DEVICE BY GEOGRAPHIC REGION
12.1 Global Blood Glucose Device Market Size Forecast by Region
12.1.1 Global Blood Glucose Device Forecast by Region (2023-2028)
12.1.2 Global Blood Glucose Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Blood Glucose Device Forecast by Type
12.7 Global Blood Glucose Device Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott Laboratories (U.S.)
13.1.1 Abbott Laboratories (U.S.) Company Information
13.1.2 Abbott Laboratories (U.S.) Blood Glucose Device Product Offered
13.1.3 Abbott Laboratories (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Laboratories (U.S.) Main Business Overview
13.1.5 Abbott Laboratories (U.S.) Latest Developments
13.2 ARKRAY (Japan)
13.2.1 ARKRAY (Japan) Company Information
13.2.2 ARKRAY (Japan) Blood Glucose Device Product Offered
13.2.3 ARKRAY (Japan) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 ARKRAY (Japan) Main Business Overview
13.2.5 ARKRAY (Japan) Latest Developments
13.3 Dexcom (U.S.)
13.3.1 Dexcom (U.S.) Company Information
13.3.2 Dexcom (U.S.) Blood Glucose Device Product Offered
13.3.3 Dexcom (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Dexcom (U.S.) Main Business Overview
13.3.5 Dexcom (U.S.) Latest Developments
13.4 F.Hoffmann-La Roche Ltd (Switzerland)
13.4.1 F.Hoffmann-La Roche Ltd (Switzerland) Company Information
13.4.2 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Offered
13.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 F.Hoffmann-La Roche Ltd (Switzerland) Main Business Overview
13.4.5 F.Hoffmann-La Roche Ltd (Switzerland) Latest Developments
13.5 Johnson & Johnson (U.S.)
13.5.1 Johnson & Johnson (U.S.) Company Information
13.5.2 Johnson & Johnson (U.S.) Blood Glucose Device Product Offered
13.5.3 Johnson & Johnson (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Johnson & Johnson (U.S.) Main Business Overview
13.5.5 Johnson & Johnson (U.S.) Latest Developments
13.6 Medtronic (U.S.)
13.6.1 Medtronic (U.S.) Company Information
13.6.2 Medtronic (U.S.) Blood Glucose Device Product Offered
13.6.3 Medtronic (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Medtronic (U.S.) Main Business Overview
13.6.5 Medtronic (U.S.) Latest Developments
13.7 Nipro Diagnostics (U.S.)
13.7.1 Nipro Diagnostics (U.S.) Company Information
13.7.2 Nipro Diagnostics (U.S.) Blood Glucose Device Product Offered
13.7.3 Nipro Diagnostics (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Nipro Diagnostics (U.S.) Main Business Overview
13.7.5 Nipro Diagnostics (U.S.) Latest Developments
13.8 Terumo Medical Corporation (U.S.)
13.8.1 Terumo Medical Corporation (U.S.) Company Information
13.8.2 Terumo Medical Corporation (U.S.) Blood Glucose Device Product Offered
13.8.3 Terumo Medical Corporation (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Terumo Medical Corporation (U.S.) Main Business Overview
13.8.5 Terumo Medical Corporation (U.S.) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Glucose Device Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Blood Glucose Device by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Blood Glucose Device by Country/Region, 2017, 2022 & 2028
2.2 Blood Glucose Device Segment by Type
2.2.1 Blood Glucose Monitors
2.2.2 Glucose Monitoring Strips
2.2.3 Lancets
2.3 Blood Glucose Device Sales by Type
2.3.1 Global Blood Glucose Device Sales Market Share by Type (2017-2022)
2.3.2 Global Blood Glucose Device Revenue and Market Share by Type (2017-2022)
2.3.3 Global Blood Glucose Device Sale Price by Type (2017-2022)
2.4 Blood Glucose Device Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics
2.4.3 Home Settings
2.4.4 Others
2.5 Blood Glucose Device Sales by Application
2.5.1 Global Blood Glucose Device Sale Market Share by Application (2017-2022)
2.5.2 Global Blood Glucose Device Revenue and Market Share by Application (2017-2022)
2.5.3 Global Blood Glucose Device Sale Price by Application (2017-2022)
3 GLOBAL BLOOD GLUCOSE DEVICE BY COMPANY
3.1 Global Blood Glucose Device Breakdown Data by Company
3.1.1 Global Blood Glucose Device Annual Sales by Company (2020-2022)
3.1.2 Global Blood Glucose Device Sales Market Share by Company (2020-2022)
3.2 Global Blood Glucose Device Annual Revenue by Company (2020-2022)
3.2.1 Global Blood Glucose Device Revenue by Company (2020-2022)
3.2.2 Global Blood Glucose Device Revenue Market Share by Company (2020-2022)
3.3 Global Blood Glucose Device Sale Price by Company
3.4 Key Manufacturers Blood Glucose Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Glucose Device Product Location Distribution
3.4.2 Players Blood Glucose Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BLOOD GLUCOSE DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Blood Glucose Device Market Size by Geographic Region (2017-2022)
4.1.1 Global Blood Glucose Device Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Blood Glucose Device Annual Revenue by Geographic Region
4.2 World Historic Blood Glucose Device Market Size by Country/Region (2017-2022)
4.2.1 Global Blood Glucose Device Annual Sales by Country/Region (2017-2022)
4.2.2 Global Blood Glucose Device Annual Revenue by Country/Region
4.3 Americas Blood Glucose Device Sales Growth
4.4 APAC Blood Glucose Device Sales Growth
4.5 Europe Blood Glucose Device Sales Growth
4.6 Middle East & Africa Blood Glucose Device Sales Growth
5 AMERICAS
5.1 Americas Blood Glucose Device Sales by Country
5.1.1 Americas Blood Glucose Device Sales by Country (2017-2022)
5.1.2 Americas Blood Glucose Device Revenue by Country (2017-2022)
5.2 Americas Blood Glucose Device Sales by Type
5.3 Americas Blood Glucose Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Glucose Device Sales by Region
6.1.1 APAC Blood Glucose Device Sales by Region (2017-2022)
6.1.2 APAC Blood Glucose Device Revenue by Region (2017-2022)
6.2 APAC Blood Glucose Device Sales by Type
6.3 APAC Blood Glucose Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood Glucose Device by Country
7.1.1 Europe Blood Glucose Device Sales by Country (2017-2022)
7.1.2 Europe Blood Glucose Device Revenue by Country (2017-2022)
7.2 Europe Blood Glucose Device Sales by Type
7.3 Europe Blood Glucose Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Glucose Device by Country
8.1.1 Middle East & Africa Blood Glucose Device Sales by Country (2017-2022)
8.1.2 Middle East & Africa Blood Glucose Device Revenue by Country (2017-2022)
8.2 Middle East & Africa Blood Glucose Device Sales by Type
8.3 Middle East & Africa Blood Glucose Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Glucose Device
10.3 Manufacturing Process Analysis of Blood Glucose Device
10.4 Industry Chain Structure of Blood Glucose Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Glucose Device Distributors
11.3 Blood Glucose Device Customer
12 WORLD FORECAST REVIEW FOR BLOOD GLUCOSE DEVICE BY GEOGRAPHIC REGION
12.1 Global Blood Glucose Device Market Size Forecast by Region
12.1.1 Global Blood Glucose Device Forecast by Region (2023-2028)
12.1.2 Global Blood Glucose Device Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Blood Glucose Device Forecast by Type
12.7 Global Blood Glucose Device Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Abbott Laboratories (U.S.)
13.1.1 Abbott Laboratories (U.S.) Company Information
13.1.2 Abbott Laboratories (U.S.) Blood Glucose Device Product Offered
13.1.3 Abbott Laboratories (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Laboratories (U.S.) Main Business Overview
13.1.5 Abbott Laboratories (U.S.) Latest Developments
13.2 ARKRAY (Japan)
13.2.1 ARKRAY (Japan) Company Information
13.2.2 ARKRAY (Japan) Blood Glucose Device Product Offered
13.2.3 ARKRAY (Japan) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 ARKRAY (Japan) Main Business Overview
13.2.5 ARKRAY (Japan) Latest Developments
13.3 Dexcom (U.S.)
13.3.1 Dexcom (U.S.) Company Information
13.3.2 Dexcom (U.S.) Blood Glucose Device Product Offered
13.3.3 Dexcom (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Dexcom (U.S.) Main Business Overview
13.3.5 Dexcom (U.S.) Latest Developments
13.4 F.Hoffmann-La Roche Ltd (Switzerland)
13.4.1 F.Hoffmann-La Roche Ltd (Switzerland) Company Information
13.4.2 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Offered
13.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 F.Hoffmann-La Roche Ltd (Switzerland) Main Business Overview
13.4.5 F.Hoffmann-La Roche Ltd (Switzerland) Latest Developments
13.5 Johnson & Johnson (U.S.)
13.5.1 Johnson & Johnson (U.S.) Company Information
13.5.2 Johnson & Johnson (U.S.) Blood Glucose Device Product Offered
13.5.3 Johnson & Johnson (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Johnson & Johnson (U.S.) Main Business Overview
13.5.5 Johnson & Johnson (U.S.) Latest Developments
13.6 Medtronic (U.S.)
13.6.1 Medtronic (U.S.) Company Information
13.6.2 Medtronic (U.S.) Blood Glucose Device Product Offered
13.6.3 Medtronic (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Medtronic (U.S.) Main Business Overview
13.6.5 Medtronic (U.S.) Latest Developments
13.7 Nipro Diagnostics (U.S.)
13.7.1 Nipro Diagnostics (U.S.) Company Information
13.7.2 Nipro Diagnostics (U.S.) Blood Glucose Device Product Offered
13.7.3 Nipro Diagnostics (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Nipro Diagnostics (U.S.) Main Business Overview
13.7.5 Nipro Diagnostics (U.S.) Latest Developments
13.8 Terumo Medical Corporation (U.S.)
13.8.1 Terumo Medical Corporation (U.S.) Company Information
13.8.2 Terumo Medical Corporation (U.S.) Blood Glucose Device Product Offered
13.8.3 Terumo Medical Corporation (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Terumo Medical Corporation (U.S.) Main Business Overview
13.8.5 Terumo Medical Corporation (U.S.) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Blood Glucose Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Blood Glucose Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Blood Glucose Monitors
Table 4. Major Players of Glucose Monitoring Strips
Table 5. Major Players of Lancets
Table 6. Global Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 7. Global Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 8. Global Blood Glucose Device Revenue by Type (2017-2022) & ($ million)
Table 9. Global Blood Glucose Device Revenue Market Share by Type (2017-2022)
Table 10. Global Blood Glucose Device Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 12. Global Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 13. Global Blood Glucose Device Revenue by Application (2017-2022)
Table 14. Global Blood Glucose Device Revenue Market Share by Application (2017-2022)
Table 15. Global Blood Glucose Device Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Blood Glucose Device Sales by Company (2020-2022) & (K Units)
Table 17. Global Blood Glucose Device Sales Market Share by Company (2020-2022)
Table 18. Global Blood Glucose Device Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Blood Glucose Device Revenue Market Share by Company (2020-2022)
Table 20. Global Blood Glucose Device Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Blood Glucose Device Producing Area Distribution and Sales Area
Table 22. Players Blood Glucose Device Products Offered
Table 23. Blood Glucose Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Blood Glucose Device Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Blood Glucose Device Sales Market Share Geographic Region (2017-2022)
Table 28. Global Blood Glucose Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Blood Glucose Device Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Blood Glucose Device Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Blood Glucose Device Sales Market Share by Country/Region (2017-2022)
Table 32. Global Blood Glucose Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Blood Glucose Device Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 35. Americas Blood Glucose Device Sales Market Share by Country (2017-2022)
Table 36. Americas Blood Glucose Device Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Blood Glucose Device Revenue Market Share by Country (2017-2022)
Table 38. Americas Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 39. Americas Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 40. Americas Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 41. Americas Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 42. APAC Blood Glucose Device Sales by Region (2017-2022) & (K Units)
Table 43. APAC Blood Glucose Device Sales Market Share by Region (2017-2022)
Table 44. APAC Blood Glucose Device Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Blood Glucose Device Revenue Market Share by Region (2017-2022)
Table 46. APAC Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 47. APAC Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 48. APAC Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 49. APAC Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 50. Europe Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 51. Europe Blood Glucose Device Sales Market Share by Country (2017-2022)
Table 52. Europe Blood Glucose Device Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Blood Glucose Device Revenue Market Share by Country (2017-2022)
Table 54. Europe Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 55. Europe Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 56. Europe Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 57. Europe Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Blood Glucose Device Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Blood Glucose Device Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Blood Glucose Device Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Blood Glucose Device
Table 67. Key Market Challenges & Risks of Blood Glucose Device
Table 68. Key Industry Trends of Blood Glucose Device
Table 69. Blood Glucose Device Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Blood Glucose Device Distributors List
Table 72. Blood Glucose Device Customer List
Table 73. Global Blood Glucose Device Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Blood Glucose Device Sales Market Forecast by Region
Table 75. Global Blood Glucose Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Blood Glucose Device Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Blood Glucose Device Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Blood Glucose Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Blood Glucose Device Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Blood Glucose Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Blood Glucose Device Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Blood Glucose Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Blood Glucose Device Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Blood Glucose Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Blood Glucose Device Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Blood Glucose Device Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Blood Glucose Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Blood Glucose Device Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Blood Glucose Device Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Blood Glucose Device Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Blood Glucose Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Blood Glucose Device Revenue Market Share Forecast by Application (2023-2028)
Table 93. Abbott Laboratories (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Abbott Laboratories (U.S.) Blood Glucose Device Product Offered
Table 95. Abbott Laboratories (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Abbott Laboratories (U.S.) Main Business
Table 97. Abbott Laboratories (U.S.) Latest Developments
Table 98. ARKRAY (Japan) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 99. ARKRAY (Japan) Blood Glucose Device Product Offered
Table 100. ARKRAY (Japan) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. ARKRAY (Japan) Main Business
Table 102. ARKRAY (Japan) Latest Developments
Table 103. Dexcom (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Dexcom (U.S.) Blood Glucose Device Product Offered
Table 105. Dexcom (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Dexcom (U.S.) Main Business
Table 107. Dexcom (U.S.) Latest Developments
Table 108. F.Hoffmann-La Roche Ltd (Switzerland) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 109. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Offered
Table 110. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. F.Hoffmann-La Roche Ltd (Switzerland) Main Business
Table 112. F.Hoffmann-La Roche Ltd (Switzerland) Latest Developments
Table 113. Johnson & Johnson (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Johnson & Johnson (U.S.) Blood Glucose Device Product Offered
Table 115. Johnson & Johnson (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Johnson & Johnson (U.S.) Main Business
Table 117. Johnson & Johnson (U.S.) Latest Developments
Table 118. Medtronic (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Medtronic (U.S.) Blood Glucose Device Product Offered
Table 120. Medtronic (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Medtronic (U.S.) Main Business
Table 122. Medtronic (U.S.) Latest Developments
Table 123. Nipro Diagnostics (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Nipro Diagnostics (U.S.) Blood Glucose Device Product Offered
Table 125. Nipro Diagnostics (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Nipro Diagnostics (U.S.) Main Business
Table 127. Nipro Diagnostics (U.S.) Latest Developments
Table 128. Terumo Medical Corporation (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 129. Terumo Medical Corporation (U.S.) Blood Glucose Device Product Offered
Table 130. Terumo Medical Corporation (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Terumo Medical Corporation (U.S.) Main Business
Table 132. Terumo Medical Corporation (U.S.) Latest Developments
Table 1. Blood Glucose Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Blood Glucose Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Blood Glucose Monitors
Table 4. Major Players of Glucose Monitoring Strips
Table 5. Major Players of Lancets
Table 6. Global Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 7. Global Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 8. Global Blood Glucose Device Revenue by Type (2017-2022) & ($ million)
Table 9. Global Blood Glucose Device Revenue Market Share by Type (2017-2022)
Table 10. Global Blood Glucose Device Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 12. Global Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 13. Global Blood Glucose Device Revenue by Application (2017-2022)
Table 14. Global Blood Glucose Device Revenue Market Share by Application (2017-2022)
Table 15. Global Blood Glucose Device Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Blood Glucose Device Sales by Company (2020-2022) & (K Units)
Table 17. Global Blood Glucose Device Sales Market Share by Company (2020-2022)
Table 18. Global Blood Glucose Device Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Blood Glucose Device Revenue Market Share by Company (2020-2022)
Table 20. Global Blood Glucose Device Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Blood Glucose Device Producing Area Distribution and Sales Area
Table 22. Players Blood Glucose Device Products Offered
Table 23. Blood Glucose Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Blood Glucose Device Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Blood Glucose Device Sales Market Share Geographic Region (2017-2022)
Table 28. Global Blood Glucose Device Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Blood Glucose Device Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Blood Glucose Device Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Blood Glucose Device Sales Market Share by Country/Region (2017-2022)
Table 32. Global Blood Glucose Device Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Blood Glucose Device Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 35. Americas Blood Glucose Device Sales Market Share by Country (2017-2022)
Table 36. Americas Blood Glucose Device Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Blood Glucose Device Revenue Market Share by Country (2017-2022)
Table 38. Americas Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 39. Americas Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 40. Americas Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 41. Americas Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 42. APAC Blood Glucose Device Sales by Region (2017-2022) & (K Units)
Table 43. APAC Blood Glucose Device Sales Market Share by Region (2017-2022)
Table 44. APAC Blood Glucose Device Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Blood Glucose Device Revenue Market Share by Region (2017-2022)
Table 46. APAC Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 47. APAC Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 48. APAC Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 49. APAC Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 50. Europe Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 51. Europe Blood Glucose Device Sales Market Share by Country (2017-2022)
Table 52. Europe Blood Glucose Device Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Blood Glucose Device Revenue Market Share by Country (2017-2022)
Table 54. Europe Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 55. Europe Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 56. Europe Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 57. Europe Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Blood Glucose Device Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Blood Glucose Device Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Blood Glucose Device Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Blood Glucose Device Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Blood Glucose Device Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Blood Glucose Device
Table 67. Key Market Challenges & Risks of Blood Glucose Device
Table 68. Key Industry Trends of Blood Glucose Device
Table 69. Blood Glucose Device Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Blood Glucose Device Distributors List
Table 72. Blood Glucose Device Customer List
Table 73. Global Blood Glucose Device Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Blood Glucose Device Sales Market Forecast by Region
Table 75. Global Blood Glucose Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Blood Glucose Device Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Blood Glucose Device Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Blood Glucose Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Blood Glucose Device Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Blood Glucose Device Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Blood Glucose Device Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Blood Glucose Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Blood Glucose Device Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Blood Glucose Device Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Blood Glucose Device Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Blood Glucose Device Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Blood Glucose Device Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Blood Glucose Device Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Blood Glucose Device Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Blood Glucose Device Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Blood Glucose Device Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Blood Glucose Device Revenue Market Share Forecast by Application (2023-2028)
Table 93. Abbott Laboratories (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Abbott Laboratories (U.S.) Blood Glucose Device Product Offered
Table 95. Abbott Laboratories (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Abbott Laboratories (U.S.) Main Business
Table 97. Abbott Laboratories (U.S.) Latest Developments
Table 98. ARKRAY (Japan) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 99. ARKRAY (Japan) Blood Glucose Device Product Offered
Table 100. ARKRAY (Japan) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. ARKRAY (Japan) Main Business
Table 102. ARKRAY (Japan) Latest Developments
Table 103. Dexcom (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 104. Dexcom (U.S.) Blood Glucose Device Product Offered
Table 105. Dexcom (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Dexcom (U.S.) Main Business
Table 107. Dexcom (U.S.) Latest Developments
Table 108. F.Hoffmann-La Roche Ltd (Switzerland) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 109. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Offered
Table 110. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. F.Hoffmann-La Roche Ltd (Switzerland) Main Business
Table 112. F.Hoffmann-La Roche Ltd (Switzerland) Latest Developments
Table 113. Johnson & Johnson (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 114. Johnson & Johnson (U.S.) Blood Glucose Device Product Offered
Table 115. Johnson & Johnson (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Johnson & Johnson (U.S.) Main Business
Table 117. Johnson & Johnson (U.S.) Latest Developments
Table 118. Medtronic (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Medtronic (U.S.) Blood Glucose Device Product Offered
Table 120. Medtronic (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Medtronic (U.S.) Main Business
Table 122. Medtronic (U.S.) Latest Developments
Table 123. Nipro Diagnostics (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Nipro Diagnostics (U.S.) Blood Glucose Device Product Offered
Table 125. Nipro Diagnostics (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Nipro Diagnostics (U.S.) Main Business
Table 127. Nipro Diagnostics (U.S.) Latest Developments
Table 128. Terumo Medical Corporation (U.S.) Basic Information, Blood Glucose Device Manufacturing Base, Sales Area and Its Competitors
Table 129. Terumo Medical Corporation (U.S.) Blood Glucose Device Product Offered
Table 130. Terumo Medical Corporation (U.S.) Blood Glucose Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Terumo Medical Corporation (U.S.) Main Business
Table 132. Terumo Medical Corporation (U.S.) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Blood Glucose Device
Figure 2. Blood Glucose Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Glucose Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Blood Glucose Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Blood Glucose Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Blood Glucose Monitors
Figure 10. Product Picture of Glucose Monitoring Strips
Figure 11. Product Picture of Lancets
Figure 12. Global Blood Glucose Device Sales Market Share by Type in 2021
Figure 13. Global Blood Glucose Device Revenue Market Share by Type (2017-2022)
Figure 14. Blood Glucose Device Consumed in Hospitals
Figure 15. Global Blood Glucose Device Market: Hospitals (2017-2022) & (K Units)
Figure 16. Blood Glucose Device Consumed in Diagnostics
Figure 17. Global Blood Glucose Device Market: Diagnostics (2017-2022) & (K Units)
Figure 18. Blood Glucose Device Consumed in Home Settings
Figure 19. Global Blood Glucose Device Market: Home Settings (2017-2022) & (K Units)
Figure 20. Blood Glucose Device Consumed in Others
Figure 21. Global Blood Glucose Device Market: Others (2017-2022) & (K Units)
Figure 22. Global Blood Glucose Device Sales Market Share by Application (2017-2022)
Figure 23. Global Blood Glucose Device Revenue Market Share by Application in 2021
Figure 24. Blood Glucose Device Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Blood Glucose Device Revenue Market Share by Company in 2021
Figure 26. Global Blood Glucose Device Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Blood Glucose Device Revenue Market Share by Geographic Region in 2021
Figure 28. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
Figure 29. Global Blood Glucose Device Revenue Market Share by Country/Region in 2021
Figure 30. Americas Blood Glucose Device Sales 2017-2022 (K Units)
Figure 31. Americas Blood Glucose Device Revenue 2017-2022 ($ Millions)
Figure 32. APAC Blood Glucose Device Sales 2017-2022 (K Units)
Figure 33. APAC Blood Glucose Device Revenue 2017-2022 ($ Millions)
Figure 34. Europe Blood Glucose Device Sales 2017-2022 (K Units)
Figure 35. Europe Blood Glucose Device Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Blood Glucose Device Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Blood Glucose Device Revenue 2017-2022 ($ Millions)
Figure 38. Americas Blood Glucose Device Sales Market Share by Country in 2021
Figure 39. Americas Blood Glucose Device Revenue Market Share by Country in 2021
Figure 40. United States Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Blood Glucose Device Sales Market Share by Region in 2021
Figure 45. APAC Blood Glucose Device Revenue Market Share by Regions in 2021
Figure 46. China Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Blood Glucose Device Sales Market Share by Country in 2021
Figure 53. Europe Blood Glucose Device Revenue Market Share by Country in 2021
Figure 54. Germany Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Blood Glucose Device Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Blood Glucose Device Revenue Market Share by Country in 2021
Figure 61. Egypt Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Blood Glucose Device in 2021
Figure 67. Manufacturing Process Analysis of Blood Glucose Device
Figure 68. Industry Chain Structure of Blood Glucose Device
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 1. Picture of Blood Glucose Device
Figure 2. Blood Glucose Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Glucose Device Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Blood Glucose Device Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Blood Glucose Device Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Blood Glucose Monitors
Figure 10. Product Picture of Glucose Monitoring Strips
Figure 11. Product Picture of Lancets
Figure 12. Global Blood Glucose Device Sales Market Share by Type in 2021
Figure 13. Global Blood Glucose Device Revenue Market Share by Type (2017-2022)
Figure 14. Blood Glucose Device Consumed in Hospitals
Figure 15. Global Blood Glucose Device Market: Hospitals (2017-2022) & (K Units)
Figure 16. Blood Glucose Device Consumed in Diagnostics
Figure 17. Global Blood Glucose Device Market: Diagnostics (2017-2022) & (K Units)
Figure 18. Blood Glucose Device Consumed in Home Settings
Figure 19. Global Blood Glucose Device Market: Home Settings (2017-2022) & (K Units)
Figure 20. Blood Glucose Device Consumed in Others
Figure 21. Global Blood Glucose Device Market: Others (2017-2022) & (K Units)
Figure 22. Global Blood Glucose Device Sales Market Share by Application (2017-2022)
Figure 23. Global Blood Glucose Device Revenue Market Share by Application in 2021
Figure 24. Blood Glucose Device Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Blood Glucose Device Revenue Market Share by Company in 2021
Figure 26. Global Blood Glucose Device Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Blood Glucose Device Revenue Market Share by Geographic Region in 2021
Figure 28. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
Figure 29. Global Blood Glucose Device Revenue Market Share by Country/Region in 2021
Figure 30. Americas Blood Glucose Device Sales 2017-2022 (K Units)
Figure 31. Americas Blood Glucose Device Revenue 2017-2022 ($ Millions)
Figure 32. APAC Blood Glucose Device Sales 2017-2022 (K Units)
Figure 33. APAC Blood Glucose Device Revenue 2017-2022 ($ Millions)
Figure 34. Europe Blood Glucose Device Sales 2017-2022 (K Units)
Figure 35. Europe Blood Glucose Device Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Blood Glucose Device Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Blood Glucose Device Revenue 2017-2022 ($ Millions)
Figure 38. Americas Blood Glucose Device Sales Market Share by Country in 2021
Figure 39. Americas Blood Glucose Device Revenue Market Share by Country in 2021
Figure 40. United States Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Blood Glucose Device Sales Market Share by Region in 2021
Figure 45. APAC Blood Glucose Device Revenue Market Share by Regions in 2021
Figure 46. China Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Blood Glucose Device Sales Market Share by Country in 2021
Figure 53. Europe Blood Glucose Device Revenue Market Share by Country in 2021
Figure 54. Germany Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Blood Glucose Device Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Blood Glucose Device Revenue Market Share by Country in 2021
Figure 61. Egypt Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Blood Glucose Device Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Blood Glucose Device in 2021
Figure 67. Manufacturing Process Analysis of Blood Glucose Device
Figure 68. Industry Chain Structure of Blood Glucose Device
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
